• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

Log in
  • Search
    • Search All SAGES Content
    • Search SAGES Guidelines
    • Search the Video Library
    • Search the Image Library
    • Search the Abstracts Archive
www.sages.org

SAGES

Reimagining surgical care for a healthier world

  • Home
    • Search
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Awards
    • Who Is SAGES?
    • Leadership
    • Our Mission
    • Advocacy
    • Committees
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Committee Rosters
      • SAGES Past Presidents
  • Meetings
    • SAGES NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2026 Scientific Session Call for Abstracts
      • 2026 Emerging Technology Call for Abstracts
    • CME Claim Form
    • SAGES Past, Present, Future, and Related Meeting Information
    • SAGES Related Meetings & Events Calendar
  • Join SAGES!
    • Membership Application
    • Membership Benefits
    • Membership Types
      • Requirements and Applications for Active Membership in SAGES
      • Requirements and Applications for Affiliate Membership in SAGES
      • Requirements and Applications for Associate Active Membership in SAGES
      • Requirements and Applications for Candidate Membership in SAGES
      • Requirements and Applications for International Membership in SAGES
      • Requirements for Medical Student Membership
    • Member Spotlight
    • Give the Gift of SAGES Membership
  • Patients
    • Join the SAGES Patient Partner Network (PPN)
    • Patient Information Brochures
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find A SAGES Surgeon
  • Publications
    • Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Sustainability in Surgical Practice
    • SAGES Stories Podcast
    • Patient Information Brochures
    • Patient Information From SAGES
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • SAGES Manuals
    • MesSAGES – The SAGES Newsletter
    • COVID-19 Archive
    • Troubleshooting Guides
  • Education
    • Wellness Resources – You Are Not Alone
    • Avoid Opiates After Surgery
    • SAGES Subscription Catalog
    • SAGES TV: Home of SAGES Surgical Videos
    • The SAGES Safe Cholecystectomy Program
    • Masters Program
    • Resident and Fellow Opportunities
      • MIS Fellows Course
      • SAGES Robotics Residents and Fellows Courses
      • SAGES Free Resident Webinar Series
      • Fluorescence-Guided Surgery Course for Fellows
      • Fellows’ Career Development Course
    • SAGES S.M.A.R.T. Enhanced Recovery Program
    • SAGES @ Cine-Med Products
      • SAGES Top 21 Minimally Invasive Procedures Every Practicing Surgeon Should Know
      • SAGES Pearls Step-by-Step
      • SAGES Flexible Endoscopy 101
    • SAGES OR SAFETY Video Activity
  • Opportunities
    • Fellowship Recognition Opportunities
    • SAGES Advanced Flexible Endoscopy Area of Concentrated Training (ACT) SEAL
    • Multi-Society Foregut Fellowship Certification
    • Research Opportunities
    • FLS
    • FES
    • FUSE
    • Jobs Board
    • SAGES Go Global: Global Affairs and Humanitarian Efforts
  • OWLS/FLS
You are here: Home / Abstracts / Surgical smoke as potential biohazard: is viral DNA contained?

Surgical smoke as potential biohazard: is viral DNA contained?

Shigeyoshi Higashi1, Yasuhiro Miyazaki2, Tomonori Makino2, Tsuyoshi Takahashi2, Yukinori Kurokawa2, Makoto Yamasaki2, Shuji Takiguchi2, Masaki Mori2, Yuichiro Doki2, Kiyokazu Nakajima1. 1Division of Next Generation Endoscopic Intervention (Project ENGINE) Global Center for Medical Engineering and Informatics, Osaka University, Osaka, Japan, 2Department of Gastroenterological Surgery Osaka University Graduate School of Medicine, Osaka, Japan

Introduction: It is widely known that surgical smoke (SS) generated by energy devices e.g. electrocautery (EC) and laparoscopic coagulating shears (LCS), includes harmful chemicals such as aldehydes and NOx. It has been recommended to recover SS actively from the point of view of risk management. However, details are not known whether SS contains viable tumor cells and/or infectious substances such as bacteria and virus. This study was aimed to clarify whether SS contains potentially bio-hazardous components such as tumor cells and viral particles.

Materials and Methods: [Tumor study] This was an ex-vivo animal study. Liver cell carcinoma cell line “PLC/PRF/5” were implanted subcutaneously in Nod/SCID mice (n=5). Tumors were intentionally ablated for 3 minutes to generate SS using EC or LCS. SS was bubbled in nuclease-free water (Ultra DW, GIBCO) via a semi-closed system with negative pressure of 10kPa. DNA was then extracted from the recovered fluid, and polymerase chain reaction (PCR) was carried out using specific primers to amplify the sequence within HBs gene of PLC/PRF/5 (200bp), those grossly band was confirmed by electrophoresis. [Virus study] This was IRB-approved, ex-vivo study using human samples. The surgically resected fresh liver samples with HBV infection were used (n=6). SS was generated by ablating non-tumorous component of the resected liver with EC or LCS in the bench-top setting. SS recovery process was performed in the same manner as Tumor study. Detection of HBV-DNA and HBs antigen in the bubbled fluid, was attempted using standard PCR method or CLIA/CLEIA method, respectively.

Results: [Tumor study] The bubbled samples were PCR positive in 80.0% (3/5) after EC activation, and 100.0% (5/5) after LCS activation, respectively. [Virus study] In serum HBV-DNA-positive liver samples (n=3), HBV-DNA was positive in 88.9% (8/9) after EC, and 77.8% (7/9) after LCS activation, respectively. In serum HBV-DNA negative liver samples (n=3), no HBV-DNA was detected. HBs antigen was negative in all bubbled fluids.

Conclusions: Fragmented tumor DNAs were detectable in SS generated by EC and LCS. Host-derived HBV-DNA was also detectable in SS generated by both EC and LCS. These data suggest that SS is oncologically and virologically bio-hazardous. Care should be taken not to expose SS to patients and operating room personnel.


Presented at the SAGES 2017 Annual Meeting in Houston, TX.

Abstract ID: 79401

Program Number: P433

Presentation Session: Poster (Non CME)

Presentation Type: Poster

124

Share this:

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on Pinterest (Opens in new window) Pinterest
  • Click to share on WhatsApp (Opens in new window) WhatsApp
  • Click to share on Reddit (Opens in new window) Reddit
  • Click to share on Pocket (Opens in new window) Pocket
  • Click to share on Mastodon (Opens in new window) Mastodon
  • Click to share on Threads (Opens in new window) Threads
  • Click to share on Bluesky (Opens in new window) Bluesky

Related


sages_adbutler_leaderboard

Hours & Info

11300 West Olympic Blvd, Suite 600
Los Angeles, CA 90064

1-310-437-0544

[email protected]

Monday – Friday
8am to 5pm Pacific Time

Find Us Around the Web!

  • Bluesky
  • X
  • Instagram
  • Facebook
  • YouTube

Copyright © 2025 · SAGES · All Rights Reserved

Important Links

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals